Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Coty Inc. Class A COTY

Coty is a global beauty company that sells fragrances (59% of fiscal 2022 revenue), color cosmetics (29%), body care (7%), and skincare (5%). It licenses brands such as Calvin Klein, Hugo Boss, Gucci, Burberry, and Davidoff for its prestige portfolio. Coty's most popular color cosmetic brands are CoverGirl, Max Factor, Rimmel, Sally Hansen, and Kylie. Coty also holds a minority stake in a salon and retail haircare business, including brands Wella, Clairol, OPI, and GHD. Francois Coty founded the firm in 1904 and it remained private until its 2013 IPO. It had focused on prestige fragrances and nail salon brands until the 2016 acquisition of Procter & Gamble's beauty business. This nearly doubled the firm's revenue base, and launched it into mass-channel cosmetics and professional hair care.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

Brazil Beauty and Personal Care Products Market Size 2021-26

According to IMARC Group’s latest report, titled “Brazil Beauty and Personal Care Products Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the market is expected to...read more

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

     rate and reply

Lithium Ionic Enters into Agreement to Acquire Strategic Mining Claims in Brazil

The three Claims to be acquired cover a total of 1,527 hectares and are located along trend with the known lithium deposits in the Itinga Pegmatite Field, including lithium producer CBL’s deposit, as well as Sigma Lithium’s Xuxa and Barreiro deposits. According to Blake Hylands, P. Geo. CEO of Lithium Ionic, “The Borges claims will significantly add to our land holdings in this highly sought-after ...read more

Vegan Cosmetics Market Size, Share, Trends Report 2022-27

According to the latest report by IMARC Group, titled “Vegan Cosmetics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” provide the global vegan...read more

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

  rate and reply

FSD Pharma Files Investigational New Drug Application “IND”

   rate and reply

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

  rate and reply

Lucid-MS for Multiple Sclerosis Treatment

  rate and reply

"Julia Levy Award" Recipient David Allan and Dr. John McGraw

   rate and reply

FSD Pharma Inc: Lucid MS Video

FSD Pharma is delighted to announce pre-clinical findings...read more

FSD: Cancellation of Certain Shares Issued to Former CEO

FSD Pharma Announces Cancellation of Certain Shares Issued to Former Chief Executive Officer Dr. Raza Bokhari   TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A)...read more

FSD Pharma Issues Corporate Updates

FSD Pharma Issues Corporate Updates TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to...read more

iMining: First Hospital Foundation in Decentraland Metaverse

iMining Enters into Agreement for the First-Ever Hospital Foundation to Be Launched in the Decentraland Metaverse   Vancouver, British Columbia--(Newsfile Corp.) - iMining Technologies Inc...read more

FSD Pharma; Recapping 2021 and What to Look Forward in 2022

  rate and reply

FSD Pharma Inc: Lucid MS Video

FSD Pharma is pleased to share pre-clinical data demonstrating the effectiveness of its lead drug candidate, Lucid-MS, in treating Multiple Sclerosis. The unique potential therapeutic value of Lucid...read more

FSD Pharma Announces Share Repurchase Program

FSD Pharma Announces Share Repurchase Program   TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding...read more

FSD Pharma Establishes New Regulatory Advisory Board

FSD Pharma Establishes New Regulatory Advisory Board with the Appointment of Joga Gobburu, Ph.D., and Mary Melnyk, Ph.D., as Members   Regulatory Advisory Board will oversee the drug development...read more

H.C. Wainwright 2nd Annual Psychedelics Virtual Conference

FSD Pharma to Present at the H.C. Wainwright 2nd Annual Psychedelics Virtual Conference on December 6th   TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD...read more

FSD Pharma at the H.C. Wainwright 2nd Annual Psychedelics

FSD Pharma to Present at the H.C. Wainwright 2nd Annual Psychedelics Virtual Conference on December 6th   TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD...read more

FSD Pharma: Demonstrating the Positive Effects of Lucid-MS

FSD Pharma Unveils Videos Demonstrating Positive Effects of...read more

📰📣iMining Technologies Launches Concierge Service📢📣📣

↓↓↓↓↓↓↓↓↓↓↓↓↓Click the link for the Full Details of the Article: ↓↓↓↓↓↓↓↓↓↓↓↓↓     BitBit Financial Inc., a wholly owned subsidiary of iMining Technologies Inc., has set-up concierge...read more